These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25859997)

  • 1. Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates.
    Garfein RS; Catanzaro DG; Rodwell TC; Avalos E; Jackson RL; Kaping J; Evasco H; Rodrigues C; Crudu V; Lin SY; Groessl E; Hillery N; Trollip A; Ganiats T; Victor TC; Eisenach K; Valafar F; Channick J; Qian L; Catanzaro A
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):420-7. PubMed ID: 25859997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations.
    Rodwell TC; Valafar F; Douglas J; Qian L; Garfein RS; Chawla A; Torres J; Zadorozhny V; Kim MS; Hoshide M; Catanzaro D; Jackson L; Lin G; Desmond E; Rodrigues C; Eisenach K; Victor TC; Ismail N; Crudu V; Gler MT; Catanzaro A
    J Clin Microbiol; 2014 Mar; 52(3):781-9. PubMed ID: 24353002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries.
    Ajbani K; Lin SY; Rodrigues C; Nguyen D; Arroyo F; Kaping J; Jackson L; Garfein RS; Catanzaro D; Eisenach K; Victor TC; Crudu V; Gler MT; Ismail N; Desmond E; Catanzaro A; Rodwell TC
    Antimicrob Agents Chemother; 2015 Jan; 59(1):414-20. PubMed ID: 25367911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis.
    Catanzaro A; Rodwell TC; Catanzaro DG; Garfein RS; Jackson RL; Seifert M; Georghiou SB; Trollip A; Groessl E; Hillery N; Crudu V; Victor TC; Rodrigues C; Lin GS; Valafar F; Desmond E; Eisenach K
    PLoS One; 2015; 10(8):e0136861. PubMed ID: 26322781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
    Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
    Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay.
    Trollip AP; Moore D; Coronel J; Caviedes L; Klages S; Victor T; Romancenco E; Crudu V; Ajbani K; Vineet VP; Rodrigues C; Jackson RL; Eisenach K; Garfein RS; Rodwell TC; Desmond E; Groessl EJ; Ganiats TG; Catanzaro A
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):227-32. PubMed ID: 24429318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant
    Varghese B; Al-Hajoj S
    Am J Trop Med Hyg; 2017 May; 96(5):1066-1070. PubMed ID: 28500800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.
    Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT
    Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
    N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the GenoType MTBDR
    Gardee Y; Dreyer AW; Koornhof HJ; Omar SV; da Silva P; Bhyat Z; Ismail NA
    J Clin Microbiol; 2017 Mar; 55(3):791-800. PubMed ID: 27974543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensively and pre-extensively drug resistant tuberculosis in clinical isolates of multi-drug resistant tuberculosis using classical second line drugs (levofloxacin and amikacin).
    Mirza IA; Khan FA; Khan KA; Satti L; Ghafoor T; Fayyaz M
    J Coll Physicians Surg Pak; 2015 May; 25(5):337-41. PubMed ID: 26008658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
    Heyckendorf J; Andres S; Köser CU; Olaru ID; Schön T; Sturegård E; Beckert P; Schleusener V; Kohl TA; Hillemann D; Moradigaravand D; Parkhill J; Peacock SJ; Niemann S; Lange C; Merker M
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates in Myanmar.
    Aung WW; Ei PW; Nyunt WW; Swe TL; Lwin T; Htwe MM; Kim KJ; Lee JS; Kim CK; Cho SN; Song SD; Chang CL
    Ann Lab Med; 2015 Sep; 35(5):494-9. PubMed ID: 26206685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India.
    Singh K; Kumari R; Gupta S; Tripathi R; Srivastava A; Shakya V; Gupta A; Anupurba S
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):56. PubMed ID: 34446022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
    Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
    J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost analysis of rapid diagnostics for drug-resistant tuberculosis.
    Groessl EJ; Ganiats TG; Hillery N; Trollip A; Jackson RL; Catanzaro DG; Rodwell TC; Garfein RS; Rodrigues C; Crudu V; Victor TC; Catanzaro A
    BMC Infect Dis; 2018 Mar; 18(1):102. PubMed ID: 29499645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.